Steward Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$72K Sell
485
-58
-11% -$8.52K 0.02% 118
2023
Q2
$73K Sell
543
-146
-21% -$21.4K 0.02% 111
2023
Q1
$109K Buy
689
+300
+77% +$45.9K 0.04% 58
2022
Q4
$62K Buy
+389
New +$59.6K 0.03% 67
2022
Q3
Sell
-551
Closed -$84K 56
2022
Q2
$84K Buy
551
+326
+145% +$49.8K 0.07% 60
2022
Q1
$36K Hold
225
0.03% 107
2021
Q4
$30K Buy
+225
New +$26.6K 0.03% 102

Other funds holding ABBV

Steward Financial Group's ABBV Position: Q3 2023 in Review

Steward Financial Group reduced its AbbVie (ABBV) stake by 11% in Q3 2023, selling an estimated $8.52K and leaving 485 shares worth $72K. The position accounts for 0.02% of the portfolio, ranked #118.

Steward Financial Group first reported a position in ABBV in Q4 2021 and has held it in 7 quarters since. The position peaked at $109K in Q1 2023. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Steward Financial Group held 485 shares of AbbVie worth $72K as of Q3 2023.
  • Steward Financial Group sold 58 AbbVie shares in Q3 2023, an estimated $8.52K.
  • AbbVie made up 0.02% of Steward Financial Group's portfolio in Q3 2023, its #118 holding.
  • Steward Financial Group first reported a position in AbbVie in Q4 2021 and has held it in 7 quarters since.
  • Steward Financial Group's AbbVie position peaked at $109K in Q1 2023.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.